1 Patient Report
1
Specimen ID: 104-988-9013-0 Control ID:
SAMPLE REPORT 1, 139900
Patient Report
Acct #: 90000999
Phone: (336) 436-8645 Rte: 00
LabCorp Test Master
Test Account
5450 Millstream Road
MCLEANSVILLE NC 27301
Patient Details DOB: 03/15/1959 Age(y/m/d): 062/00/30 Gender: M Patient ID:
Specimen Details Date collected: 04/14/2021 0000 Local Date received: 04/14/2021 Date entered: 04/14/2021 Date reported: 04/14/2021 0855 ET
Physician Details Ordering: Referring: ID: NPI:
General Comments & Additional Information Clinical Info: NOT DETECTED
Ordered Items SARS-CoV-2, NAA
TESTS
RESULT
FLAG
UNITS REFERENCE INTERVAL LAB
SARS-CoV-2, NAA
SARS-CoV-2, NAA
Not Detected
Not Detected
01
This nucleic acid amplification test was developed and its performance
characteristics determined by LabCorp Laboratories. Nucleic acid
amplification tests include RT-PCR and TMA. This test has not been
FDA cleared or approved. This test has been authorized by FDA under
an Emergency Use Authorization (EUA). This test is only authorized
for the duration of time the declaration that circumstances exist
justifying the authorization of the emergency use of in vitro
diagnostic tests for detection of SARS-CoV-2 virus and/or diagnosis
of COVID-19 infection under section 564(b)(1) of the Act, 21 U.S.C.
360bbb-3(b) (1), unless the authorization is terminated or revoked
sooner.
When diagnostic testing is negative, the possibility of a false
negative result should be considered in the context of a patient's
recent exposures and the presence of clinical signs and symptoms
consistent with COVID-19. An individual without symptoms of COVID-19
and who is not shedding SARS-CoV-2 virus would expect to have a
negative (not detected) result in this assay.
SARS-CoV-2, NAA 2 DAY TAT
Performed
02
01 BN
LabCorp Burlington
1447 York Court, Burlington, NC 27215-3361
02 $$
Testmaster Testing
3060 S Church Street, Burlington, NC 27215
For inquiries, the physician may contact Branch: 800-222-7566 Lab: 336-436-2762
Dir: Sanjai Nagendra, MD Dir: Report Testing, PhD
Date Issued: 04/14/21 0857 ET
FINAL REPORT
This document contains private and confidential health information protected by state and federal law. If you have received this document in error, please call 800-222-7566
Page 1 of 1
1995-2021 Laboratory Corporation of America Holdings All Rights Reserved - Enterprise Report Version: 1.00
1
Specimen ID: 104-988-9014-0 Control ID:
SAMPLE REPORT 2, 139900
Patient Report
Acct #: 90000999
Phone: (336) 436-8645 Rte: 00
LabCorp Test Master
Test Account
5450 Millstream Road
MCLEANSVILLE NC 27301
Patient Details DOB: 02/02/1982 Age(y/m/d): 039/02/12 Gender: M Patient ID:
Specimen Details Date collected: 04/14/2021 0000 Local Date received: 04/14/2021 Date entered: 04/14/2021 Date reported: 04/14/2021 1443 ET
Physician Details Ordering: Referring: ID: NPI:
General Comments & Additional Information Clinical Info: DETECTED
Ordered Items SARS-CoV-2, NAA
TESTS
RESULT
FLAG
UNITS REFERENCE INTERVAL LAB
SARS-CoV-2, NAA
SARS-CoV-2, NAA
Detected Abnormal
Not Detected
01
Patients who have a positive COVID-19 test result may now have
treatment options. Treatment options are available for patients
with mild to moderate symptoms and for hospitalized patients.
Visit our website at for
resources and information.
This nucleic acid amplification test was developed and its performance
characteristics determined by LabCorp Laboratories. Nucleic acid
amplification tests include RT-PCR and TMA. This test has not been
FDA cleared or approved. This test has been authorized by FDA under
an Emergency Use Authorization (EUA). This test is only authorized
for the duration of time the declaration that circumstances exist
justifying the authorization of the emergency use of in vitro
diagnostic tests for detection of SARS-CoV-2 virus and/or diagnosis
of COVID-19 infection under section 564(b)(1) of the Act, 21 U.S.C.
360bbb-3(b) (1), unless the authorization is terminated or revoked
sooner.
When diagnostic testing is negative, the possibility of a false
negative result should be considered in the context of a patient's
recent exposures and the presence of clinical signs and symptoms
consistent with COVID-19. An individual without symptoms of COVID-19
and who is not shedding SARS-CoV-2 virus would expect to have a
negative (not detected) result in this assay.
SARS-CoV-2, NAA 2 DAY TAT
Performed
02
01 BN
LabCorp Burlington
1447 York Court, Burlington, NC 27215-3361
02 $$
Testmaster Testing
3060 S Church Street, Burlington, NC 27215
For inquiries, the physician may contact Branch: 800-222-7566 Lab: 336-436-2762
Dir: Sanjai Nagendra, MD Dir: Report Testing, PhD
Date Issued: 04/14/21 1444 ET
FINAL REPORT
This document contains private and confidential health information protected by state and federal law. If you have received this document in error, please call 800-222-7566
Page 1 of 1
1995-2021 Laboratory Corporation of America Holdings All Rights Reserved - Enterprise Report Version: 1.00
1
Specimen ID: 104-988-9015-0 Control ID:
SAMPLE REPORT 3, 139900
Patient Report
Acct #: 90000999
Phone: (336) 436-8645 Rte: 00
LabCorp Test Master
Test Account
5450 Millstream Road
MCLEANSVILLE NC 27301
Patient Details DOB: 07/04/1976 Age(y/m/d): 044/09/10 Gender: M Patient ID:
Specimen Details Date collected: 04/14/2021 0000 Local Date received: 04/14/2021 Date entered: 04/14/2021 Date reported: 04/14/2021 0855 ET
Physician Details Ordering: Referring: ID: NPI:
General Comments & Additional Information Clinical Info: INDETERMINATE
Ordered Items SARS-CoV-2, NAA
TESTS
RESULT
FLAG
UNITS REFERENCE INTERVAL LAB
SARS-CoV-2, NAA
SARS-CoV-2, NAA
Indeterminate Abnormal
Not Detected
01
We are UNABLE to reliably determine a result for the specimen due to
the inconsistent amplification of all of the required SARS-CoV-2
components from the specimen submitted. If clinically indicated,
please recollect an additional specimen for testing.
This nucleic acid amplification test was developed and its performance
characteristics determined by LabCorp Laboratories. Nucleic acid
amplification tests include RT-PCR and TMA. This test has not been
FDA cleared or approved. This test has been authorized by FDA under
an Emergency Use Authorization (EUA). This test is only authorized
for the duration of time the declaration that circumstances exist
justifying the authorization of the emergency use of in vitro
diagnostic tests for detection of SARS-CoV-2 virus and/or diagnosis
of COVID-19 infection under section 564(b)(1) of the Act, 21 U.S.C.
360bbb-3(b) (1), unless the authorization is terminated or revoked
sooner.
When diagnostic testing is negative, the possibility of a false
negative result should be considered in the context of a patient's
recent exposures and the presence of clinical signs and symptoms
consistent with COVID-19. An individual without symptoms of COVID-19
and who is not shedding SARS-CoV-2 virus would expect to have a
negative (not detected) result in this assay.
SARS-CoV-2, NAA 2 DAY TAT
Performed
02
01 BN
LabCorp Burlington
1447 York Court, Burlington, NC 27215-3361
02 $$
Testmaster Testing
3060 S Church Street, Burlington, NC 27215
For inquiries, the physician may contact Branch: 800-222-7566 Lab: 336-436-2762
Dir: Sanjai Nagendra, MD Dir: Report Testing, PhD
Date Issued: 04/14/21 0859 ET
FINAL REPORT
This document contains private and confidential health information protected by state and federal law. If you have received this document in error, please call 800-222-7566
Page 1 of 1
1995-2021 Laboratory Corporation of America Holdings All Rights Reserved - Enterprise Report Version: 1.00
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- guidelines for a physics lab reports
- memory lab report example 1 discovering statistics
- i question ii variables iii hypothesis iv materials
- writing a lab report chemistry
- sample paper one experiment paper
- 1 patient report
- physics laboratory report sample
- perception of different sugars by blowflies
- human ecg laboratory experiment by brittany baierlein
Related searches
- 3 in 1 credit report free
- eeo 1 report sample
- sample eeo 1 report template
- eeo 1 report form printable
- 1 or 2 374 374 1 0 0 0 1 168 1 1 default username and password
- 1 or 3 374 374 1 0 0 0 1 168 1 1 default username and password
- 1 or 2 711 711 1 0 0 0 1 168 1 1 default username and password
- 1 or 3 711 711 1 0 0 0 1 168 1 1 default username and password
- 1 or 2 693 693 1 0 0 0 1 168 1 1 default username and password
- 1 or 3 693 693 1 0 0 0 1 168 1 1 default username and password
- 1 or 2 593 593 1 0 0 0 1 or 2dvchrbu 168 1 1 default username and password
- 1 or 3 593 593 1 0 0 0 1 or 2dvchrbu 168 1 1 default username and password